Summary blastoma (13 patients), seminoma (6 patients), teratoma (5 patients), embrybnic sarcoma (5 patienis), r h a b d~m~o s a r c o h a ' (3 P~r"va" kinas' and ~~~~~~o~~' c t o~n a s e isoz~mic exPressi0" patients) and ~~i~~~~ tumor (1 patient) ~h~ level of differentiahave investigated in 62 chi'dhood cancers electrOfwusing tion of neurob~astomas was highly variable from one observation and immunoneutralization. Isozymic expression was roughly inter-to another Some of them, relatively well differentiated. were mediate between that of the corresponding and classified as ganglioneumrnas and ganglioneuroblastomas whereas tissue. There were unique features distinguishing malignant from others, undifferentiated, were considered as true neuroblastomas. both adult and fetal tissues. In addition, phosphofructokinase and Biochemical methods. extraction and immunoneutralipyruvate liinase be excel1ent markers nervous zation of phosphof~c~okinase by specific anti M, anti L and anti tissue and skeletal muscle differentiation. In neuroblastomas there performed as previously described ( 13, 19) . was a close relationship between the differentiation level of tumors Py,vate kinase isozymes were resolved by polyacrylamide slab and their isozyme composition' The same phenomenon was o b gel e~ectrophoresis (17) , and stained by tetrazolium salt-linked served in rhabdomyosarcomas and teratomas.
reaction with inhibition of adenylate kinase reaction by excess AMP (1). Specificity of the staining was checked by omitting Speculation phosphoenolpyruvate from some staining mixtures. ~~l~i~l~ isozymic markers could be used as a to detect Control tissues came from 3-to 4-month-old fetuses (lo, 17). some types of tumoral differentiation, the degree of this differentiation and, in some cases, degree of malignancy. In addition, the RESULTS fact that the malignant tissue isozymic patterns studied never appear to be exactly similar to their normal fetal counterpart Isoelectric focusing is a very resolutive technique that can reveal suggests that malignancy is associated with a special pattern of many as lo discrete pyruvate bands (Fig. I) . Some of differentiation rather than to indifferentiation or &-differentiation these bands probably the various tetrameric alone.
binations of K and M subunits while others probably reflect microheterogeneity. Inasmuch as it is not feasible to determine with certainty the subunit composition of each active band, they Pyruvate kinase (ATP: pyruvate phosphotransferase, EC will be numbered from I (most cathodic form corresponding to 2.7.1.40) and phosphofructokinase (ATP: D-fructose 6 phosphate M4 isozyme) to 10 (most anodic form). The classical K4 isozyme I-phosphotransferase, EC 2.7.1.1 1) occur in multiple isozymic Present in human fibroblasts migrates as band 8 (Fig. 1) . We forms in mammalian tissues (c$ ref. 8) . The basic pyruvate kinase verified, using antihuman L-type pyruvate kinase antiserum, that isozymes (i.e., composed of a single type of subunit) are L (major the anodic forms did not correspond to hybrids including L form in liver), R (major form in red cells), M2 or K (major form subunits. in kidney), and M I or M (major forin in adult skeletal muscle and Nephroblastomas. Practically all the nephroblastomas studied adult brain) (8) . We have shown that L and R pyruvate kinases exhibited very similar isozymic patterns with K4 as the predomiare encoded by the same gene ( 12. 18) . Whether M and K subunits, nant PYmvate kinase form and synthesis of all three types of which are immunologically indistinguishable, are encoded or not ~hosphofructokinase subunits. These patterns are not profoundly by separate genes is still in dispute (6, 7, 17, 21) . For phospho-different from those observed in either adult or fetal kidney (Table  fructokinase, we and others have shown that it is encoded by three 1 ). Pymvate kinase isozymes are the same in nephroblastomas separate genes, the products of which are subunits M (predomi-and fetal kidney whereas the major isozyme observed in the adult nant in the muscle), L (predominant in the liver), and F (predomi-Organ is slightly more cathodic. The three types of phosphofrucnant in fibroblasts and abundant in platelets) (2, 11, 13, 15, 27) . tokinase in nephroblastomas seem to be expressed in approximaWe have previously studied pyruvate kinase and phosphof~cto-tively equivalent amounts whereas in adult kidney the predomikinase isozymes in human adults or fetuses (10. 17) . In this paper, nant form is F and in fetal kidney, L. In three tumors. however. we compare isozymic expression of these enzymes in various types pho~phofructokinase expression was clearly different from that of childhood cancers to that of the corresponding normal, fetal or reported above, M -~Y P~ being the predominant form. In one of adult tissues. The combination of pyruvate kinase and phospho-these tumors, histologic examination detected the presence of fructokinase isozyrne determination permits assessment of type skeletal muscle differentiation. and degree of differentiation of some malignant childhood tumors. Neuroblastomas ( Table 2) . ,411 samples of childhood neuroblastomas were characterized by the presence of the cathodic (M) MATERIALS AND METHODS form of pyruvate kinase and of F-type phosphofructokinase as the major phosphofructokinase subunit; these features are characterPatients. Tumor samples studied were obtained from surgical istic of adult differentiated brain tissue. Some marked differences. biopsies or exereses and stored frozen at -70°C until use. The however, exist between the various tumors according to their level pathologic diagnoses were: nephroblastoma (28 patients), neuro-of differentiation: anodic pyruvate kinase isozymes ( K and K-M (17) after a prerun of I h and focalisation ran for 4 h at 2"C, with a final voltage of 700 volts (17) . Positive staining as in (1). with addition of 12 mM .AMP in order to inhibit adenylate kinase activity. 1, fetal muscle; 2, fibroblast; 3, sympathoblastoma; 4, nephroblastoma; 5, teratoma; 6, rhabdomyosarcoma; 7, nephroblastoma; 8, well differentiated rhabdomyosarcoma; 9, neuroblastoma; and 10, nephroblastoma.
hybrids) were observed in all the poorly differentiated tissueh except one (neuroblastoma 5, Table 1 ) but not in any of the welldifferentiated tumors (i.e., ganglioneuroblastomas and ganglioneuromas). L-type phosphofructokinase, abundant in fetal brain. was more abundant in undifferentiated tumors (mean residual activity after immunoneutralization by anti L-type antiserum: 37%) than in ganglioneuroblastomas (57%) and ganglioneuromas (70%).
\ ,
Miscellaneous (Table 3) . Seminomas, undifferentiated teratomah and embryonic sarcomas gave an "undifferentiated cell" isozym~c pattern characterized by indiscriminate synthesis of the three types of phosphofructokinase isozymes (L always being the predominant form) and the presence of anodic pyruvate kinase forms (K isozyme). In one observation of a teratoma that contained nervous structures, we found abundant muscle-type phosphofructokinase and some cathodic (M) pyruvate kinase isozymes. Phosphofructokinase isozymic composition of three rhabdomyosarcomas was different in each case and did not seem to be specific for a special type of differentiation. In contrast, both tumors with marked skeletal muscle differentiation synthesized cathodic pyruvate kinase isozymes. Most surprisingly, a tumor considered by the pathologists as an "Ewing's tumor" was found to be very similar to neuroblastomas, namely with synthesis of F-type phosphofructokinase as the major form and of cathodic pyruvate kinase isozymes. ' The results of maximal phosphofructokinase immunoneutralization in nephroblastomas are given + 1 S.D.
'Relative intensity of pyruvate kinase active bands resolved by electrofocusing is semiquantitatively evaluated; band I corresponds to classical MI isozyme and band 8 to K4 isozyme. " The data concerning adult and fetal tissues came from previous papers whose references are given in the parentheses: the values indicated represent the extreme limits of eight individual determinations. anti M anti L a n t i F Modification of isozymic patterns in cancer has been studied for several years. In general, the main characteristic is the reappearance or increase of synthesized forms in the fetus and in nondifferentiated cells (9, 22) , e.g., pyruvate kinase K (1, 5, 24), aldolases A (23) and non-L phosphofructokinase (4, 14, 16) in hepatomas. It is obvious that all malignant cells are not similar and, for a given cell type, correspond to different degrees of differentiation. The question is whether some isozymes can also be used as indicators of cell type and of the stage of differentiation of the tumors. Van Veelen et al. (26) and Tolle et al. (25) have shown that this was true for pyruvate kinase in human and rodent brain tumors. It is also known that some differentiated rat hepatomas synthesized L-type pyruvate kinase, L-type phosphofructokinase and aldolase B as do normal adult hepatocytes (3, 20) .
The main implications of the results reported in this paper are:
(1) That isozymic expression of childhood tumoral cells is roughly intermediate between that of the corresponding adult and fetal tissues but often includes some unique features not found in either adult or fetal tissues.
(2) That phosphofructokinase and pyruvate kinase are good markers for certain types of cell differentiation, namely nervous tissue and skeletal muscle differentiation. Fetal and adult kidney tissue exhibit similar pyruvate kinase and phosphofructokinask patterns; as expected, this pattern is not profoundly modified in nephroblastomas. In three cases, however, synthesis of M-type phosphofructokinase as the major form could indicate some degree of muscular differentiation, which in one case was histologically documented. All the neuroblastomas studied had common features with both adult and fetal brain: in adult brain, F-type phosphofructokinase is always the major subunit; in fetal brain, some L-type phosphofructokinase is synthesized, and both K and M pyruvate kinase forms are expressed. Moreover, isozymic composition closely reflects level of differentiation: immature tumorous cells synthesize more L-type phosphofructokinase and K pyruvate kinase forms (similar to fetal brain) than more mature tumorous cells. None of the brain tumors studied exactly resembled normal fetal or adult brain pyruvate kinase and phosphofructokinase isozyme patterns. Those tumors with K-M pyruvate kinase hybrid expression, i.e., resembling fetal brain for this marker, synthesize far more F-type and less M-type phosphofructokinase than fetal brain. Such a dissociation between these two systems of isozymic markers indicates that tumorous nervous cells should be considered as cells having a unique type of differentiation rather than as de-differentiated or undifferentiated cells.
(3) Seminomas, undifferentiated teratomas and embryonic sar-(lo), namely expression of the most anodic pyruvate kinase forms and indiscriminate synthesis of all three phosphofructokinase subunits. As indicated above, skeletal muscle and nervous tissue differentiations are easily recognized. For instance, a teratoma containing nervous structures and synthesizing large amounts of cathodic pyruvate kinase forms and muscle-type phosphofructokinase, displayed the same phenomenon as were observed for two relatively differentiated rhabdomyosarcomas. (4) Finally, in one case, the pyruvate kinase isozymic pattern was totally unexpected. An Ewing's tumor, normally considered as of histiocytic origin, exhibited cathodic type pyruvate kinase. The presence of K-M pyruvate kinase hybrids and the phosphofructokinase isozymic pattern meant that these results could not be due to the presence of skeletal muscle in the biopsy sample. Inasmuch as only one sample of this type of tumor has been studied, it is impossible to discuss the significance of these findings.
In conclusion, comparison of phosphofructokinase and pyruvate kinase isozymic patterns of different types of childhood tumors confirms the general phenomenon of malignancy-linked de-differentiation, constitutes an accurate indication of skeletal muscle and nervous tissue differentiation, and sometimes reflects some unique characteristics of tumor cells.
